The role of redox-active metals in the mechanism of action of bleomycin
- PMID: 1690086
- DOI: 10.1016/0009-2797(90)90001-4
The role of redox-active metals in the mechanism of action of bleomycin
Abstract
Belomycin is a glycopeptide antibiotic routinely used to treat human cancer. It is commonly thought to exert its biological effects as a metallodrug, which oxidatively damages DNA. This review systematically examines the properties of bleomycin which contribute to its reaction with DNA in vitro and may be important in the breakage of DNA in cells. Because strand cleavage results from the reductive activation of dioxygen by metallobleomycins, the mechanism of this process is given primary attention. Current understanding of the structures of the coordination sites of various metallobleomycins, their thermodynamic stabilities, their propensity to form adduct species, and their properties in ligand substitution reactions provide a foundation for consideration of the chemistry of dioxygen activation as well as a basis for thinking about the metal-speciation of bleomycin in biological systems. Oxidation-reduction pathways of iron-bleomycin, copper-bleomycin, and other metal-bleomycin species with O2 are then examined, including information on photochemical activation. With this background, structural and thermodynamic features of the binding interactions of DNA with bleomycin, its metal complexes, and adducts of metallobleomycins are reviewed. Then, the DNA cleavage reaction involving iron-bleomycin is scrutinized on the basis of the preceding discussion. Particular emphasis is placed on the constraints which the presence of DNA places on the mechanism of dioxygen activation. Similarly, the reactions of other metalloforms of bleomycin with DNA are reviewed. The last topic is an analysis of current understanding of the relationship of bleomycin-induced cellular DNA damage to the model developed above, which has evolved on the basis of chemical experimentation. Consideration is given to the question of the importance of DNA strand breakage caused by bleomycin for the mechanism of cytotoxic activity of the drug.
Similar articles
-
Synthetic analogues and biosynthetic intermediates of bleomycin. Metal-binding, dioxygen interaction, and implication for the role of functional groups in bleomycin action mechanism.J Biol Chem. 1983 Jan 25;258(2):1328-36. J Biol Chem. 1983. PMID: 6185478
-
Studies on the chemical reactivity of copper bleomycin.J Inorg Biochem. 1982 Oct;17(2):75-94. doi: 10.1016/s0162-0134(00)80077-x. J Inorg Biochem. 1982. PMID: 6184448
-
DNA cleavages of bleomycin-transition metal complexes induced by reductant, hydrogen peroxide, and ultraviolet light: characteristics and biological implication.Nucleic Acids Symp Ser. 1984;(15):161-4. Nucleic Acids Symp Ser. 1984. PMID: 6084237
-
Photoreactivity of bleomycin and its implications.Bull Cancer. 1983;70(5):372-80. Bull Cancer. 1983. PMID: 6199058 Review.
-
DNA strand scission by activated bleomycin group antibiotics.Fed Proc. 1986 Nov;45(12):2784-91. Fed Proc. 1986. PMID: 2429877 Review.
Cited by
-
The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin.Front Pharmacol. 2022 Sep 30;13:985223. doi: 10.3389/fphar.2022.985223. eCollection 2022. Front Pharmacol. 2022. PMID: 36249808 Free PMC article.
-
Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer.Redox Biol. 2013 Nov 26;2:22-7. doi: 10.1016/j.redox.2013.11.005. eCollection 2013. Redox Biol. 2013. PMID: 24396727 Free PMC article.
-
Mechanism of DNA-drug interactions.Appl Biochem Biotechnol. 1994 Apr;47(1):39-55. doi: 10.1007/BF02788674. Appl Biochem Biotechnol. 1994. PMID: 8203870 Review.
-
Successful Treatment of Low-Flow Vascular Malformation in the Lip Using Intralesional Bleomycin: A Case Report.Cureus. 2024 Nov 20;16(11):e74119. doi: 10.7759/cureus.74119. eCollection 2024 Nov. Cureus. 2024. PMID: 39712813 Free PMC article.
-
Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand.Jpn J Cancer Res. 1998 Sep;89(9):947-53. doi: 10.1111/j.1349-7006.1998.tb00653.x. Jpn J Cancer Res. 1998. PMID: 9818031 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources